Research ArticleOriginal Article
Open Access
The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients
Is there a room for vitamin D?
Hatouf H. Sukkarieh, Rami T. Bustami, Manasik N. Abdu, Ayesha A. Khokhar, Amir A. Salih and Hana K. Abdalla
Saudi Medical Journal October 2020, 41 (10) 1083-1089; DOI: https://doi.org/10.15537/smj.2020.10.25428
Hatouf H. Sukkarieh
From the Department of Pharmacology (Sukkarieh), from the Department of Operations & Project Management (Bustami), from the College of Medicine (Abdu, Khokhar), from the Department of Microbiology and Immunology (Abdalla), Alfaisal University, Riyadh; and from the from the Department of Internal Medicine (Salih), Almana General Hospital, Dammam, Kingdom of Saudi Arabia
PhDRami T. Bustami
From the Department of Pharmacology (Sukkarieh), from the Department of Operations & Project Management (Bustami), from the College of Medicine (Abdu, Khokhar), from the Department of Microbiology and Immunology (Abdalla), Alfaisal University, Riyadh; and from the from the Department of Internal Medicine (Salih), Almana General Hospital, Dammam, Kingdom of Saudi Arabia
PhDManasik N. Abdu
From the Department of Pharmacology (Sukkarieh), from the Department of Operations & Project Management (Bustami), from the College of Medicine (Abdu, Khokhar), from the Department of Microbiology and Immunology (Abdalla), Alfaisal University, Riyadh; and from the from the Department of Internal Medicine (Salih), Almana General Hospital, Dammam, Kingdom of Saudi Arabia
MBBSAyesha A. Khokhar
From the Department of Pharmacology (Sukkarieh), from the Department of Operations & Project Management (Bustami), from the College of Medicine (Abdu, Khokhar), from the Department of Microbiology and Immunology (Abdalla), Alfaisal University, Riyadh; and from the from the Department of Internal Medicine (Salih), Almana General Hospital, Dammam, Kingdom of Saudi Arabia
HSDGAmir A. Salih
From the Department of Pharmacology (Sukkarieh), from the Department of Operations & Project Management (Bustami), from the College of Medicine (Abdu, Khokhar), from the Department of Microbiology and Immunology (Abdalla), Alfaisal University, Riyadh; and from the from the Department of Internal Medicine (Salih), Almana General Hospital, Dammam, Kingdom of Saudi Arabia
MDHana K. Abdalla
From the Department of Pharmacology (Sukkarieh), from the Department of Operations & Project Management (Bustami), from the College of Medicine (Abdu, Khokhar), from the Department of Microbiology and Immunology (Abdalla), Alfaisal University, Riyadh; and from the from the Department of Internal Medicine (Salih), Almana General Hospital, Dammam, Kingdom of Saudi Arabia
PhDArticle Figures & Data
Tables
In this issue
The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients
Hatouf H. Sukkarieh, Rami T. Bustami, Manasik N. Abdu, Ayesha A. Khokhar, Amir A. Salih, Hana K. Abdalla
Saudi Medical Journal Oct 2020, 41 (10) 1083-1089; DOI: 10.15537/smj.2020.10.25428
The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients
Hatouf H. Sukkarieh, Rami T. Bustami, Manasik N. Abdu, Ayesha A. Khokhar, Amir A. Salih, Hana K. Abdalla
Saudi Medical Journal Oct 2020, 41 (10) 1083-1089; DOI: 10.15537/smj.2020.10.25428
Jump to section
Related Articles
- No related articles found.
Cited By...
- Comment on: The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?
- Comment on: The current practice of using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in diabetic hypertensive and non-hypertensive patients. Is there a room for vitamin D?